Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions
ADHD - Attention Deficit Disorder With HyperactivityADHD - Combined TypeADHD
Interventions
DEVICE

Model Name: EMT-SR01;red

The investigational device incorporated both a driving simulation and an N-Back cognitive training function. These features were designed to engage and improve key cognitive abilities such as attention, working memory, and executive function, which are often impaired in individuals with ADHD. The combined use of driving tasks and N-Back exercises aimed to provide a comprehensive and interactive therapeutic intervention to reduce core ADHD symptoms.

DEVICE

Model Name: EMT-SR01;red (Placebo)

The placebo device incorporated only the driving simulation function and excluded the N-Back cognitive training component. The driving simulation was designed as a sham intervention to mimic the user experience without providing the active therapeutic elements targeting cognitive functions. This setup enabled a controlled comparison with the active digital therapeutic device.

Trial Locations (1)

06179

Emotiv, Seoul

All Listed Sponsors
lead

EMOTIV

INDUSTRY

NCT07173439 - Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD | Biotech Hunter | Biotech Hunter